Design Therapeutics
DSGN · NASDAQ
$11.10+$0.46 (+4.32%)TodayMarket closed ·
Prev close $10.64
Who owns DSGN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 66.3% of DSGN’s shares.
- Ansari (Aseem Z. Ph.D.)12.3%
- SR One Capital Management, LP10.4%
- Sirenia Capital Management LP8.7%
- Light Irrevocable Trust.6.1%
- Next 6 largest institutions28.7%
- All other shareholders33.7%
| Holder | Shares | % of shares |
|---|---|---|
| Ansari (Aseem Z. Ph.D.) | 7.67M | 12.28% |
| SR One Capital Management, LP | 6.53M | 10.45% |
| Sirenia Capital Management LP | 5.45M | 8.73% |
| Light Irrevocable Trust. | 3.83M | 6.14% |
| Star Irrevocable Trust. | 3.83M | 6.14% |
| Quan Venture Fund II LP | 3.38M | 5.42% |
| Logos Global Management LP | 3.00M | 4.80% |
| Baker Bros. Advisors LP | 2.68M | 4.29% |
| Driehaus Capital Management, LLC | 2.66M | 4.26% |
| Point72 Asset Management, L.P. | 2.37M | 3.79% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.16M | 1.86% |
| iShares Russell 2000 ETF | 812.83K | 1.30% |
| Fidelity Select Biotechnology Portfolio | 534.93K | 0.86% |
| Vanguard Extended Market Index Fund | 374.52K | 0.60% |
| Driehaus US Micro Cap Equity Fund | 348.60K | 0.56% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of DSGN in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Gover Justin D. | Award | 30.00K | — |
| Berger Heather A. | Award | 30.00K | — |
| George Simeon | Award | 30.00K | — |
| LAPPE RODNEY W | Award | 30.00K | — |
| Shapiro David | Award | 30.00K | — |
| Schmid John P. | Award | 30.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 6.62M
- Days to cover
- 8.69
- % of shares outstanding
- 10.59%
- Average daily volume
- 761.01K
- Change since last report
- +21.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.